| Title |
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd007104.pub2 |
| Pubmed ID | |
| Authors |
Magali Lecavalier-Barsoum, Harvey Quon, Bassam Abdulkarim |
| Abstract |
Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. The benefit of adjuvant chemotherapy and radiotherapy (RT), given as single modalities or sequentially, is still unclear. Furthermore, insight into the predictive and prognostic impact of various biomarkers is surging. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 112 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 13 | 12% |
| Student > Master | 12 | 11% |
| Student > Ph. D. Student | 11 | 10% |
| Researcher | 8 | 7% |
| Student > Doctoral Student | 8 | 7% |
| Other | 20 | 18% |
| Unknown | 40 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 36% |
| Nursing and Health Professions | 7 | 6% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Neuroscience | 5 | 4% |
| Computer Science | 2 | 2% |
| Other | 10 | 9% |
| Unknown | 43 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2020.
All research outputs
#6,778,124
of 22,756,196 outputs
Outputs from Cochrane database of systematic reviews
#8,439
of 12,314 outputs
Outputs of similar age
#65,072
of 226,949 outputs
Outputs of similar age from Cochrane database of systematic reviews
#162
of 229 outputs
Altmetric has tracked 22,756,196 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,949 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 229 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.